Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies

Clinical trial NCT02025985 · COMPLETED

Trial details

NCT number: NCT02025985
Sponsor: Karyopharm Therapeutics Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Carcinoma Endometrial Carcinoma Cervical Carcinoma

Start date: 2014-04-09
Primary completion: 2017-01-24
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.